Production Quiz 02

Production Quiz 02

Question: What is mottling, and what factors contribute to this defect in tablets?

Answer: Mottling is a tablet defect that can be caused by colored drugs (Excipient-related), improper mixing of granular material (Process-related), dirt in the granular material, or the use of oily lubricant, leading to oil spots.

Answer: How does the color of a drug contribute to mottling?

A2: Mottling can occur if a drug with a color different from the rest of the granular material is used, contributing to the defect.

Question: What role does improper mixing play in the occurrence of mottling in tablets?

Answer: Improper mixing of granular material during the tableting process can contribute to the occurrence of mottling.

Question: How can dirt in the granular material or on punch faces lead to mottling in tablets?

Answer: The presence of dirt in the granular material or on punch faces during tablet manufacturing can contribute to the defect of mottling.

Question: What is the cause of double impressions in tablet production?

Answer: Double impression occurs due to the free rotation of punches with engraving on their faces during tablet manufacturing.

Question: How is mottling related to formulation and machine factors?

Answer: Mottling can be related to formulation issues (granulation) such as colored drugs and machine-related factors like improper mixing, dirt, and the use of oily lubricant.

Question: What are the potential remedies for mottling in tablets?

Answer: Remedies for mottling may include addressing the factors contributing to the defect, such as using proper mixing techniques, avoiding colored drugs causing mottling, and ensuring cleanliness.

Question: How does the free rotation of punches contribute to double impression in tablet production?

Answer: Double impression occurs when punches with engraving on their faces experience free rotation during tablet manufacturing.

Production Quiz 01

About Pharmaguidanaces Channel

Ms. Abha Maurya is the Author and founder of pharmaceutical guidance, he is a pharmaceutical Professional from India having more than 18 years of rich experience in pharmaceutical field. During his career, he work in quality assurance department with multinational company’s i.e Zydus Cadila Ltd, Unichem Laboratories Ltd, Indoco remedies Ltd, Panacea Biotec Ltd, Nectar life Science Ltd. During his experience, he face may regulatory Audit i.e. USFDA, MHRA, ANVISA, MCC, TGA, EU –GMP, WHO –Geneva, ISO 9001-2008 and many ROW Regularities Audit i.e.Uganda,Kenya, Tanzania, Zimbabwe. He is currently leading a regulatory pharmaceutical company as a head Quality. You can join him by Email, Facebook, Google+, Twitter and YouTube

Check Also

PROCESS VALIDATION PROTOCOL OF TACROLIMUS CAPSULES

PROCESS VALIDATION PROTOCOL  TACROLIMUS CAPSULES Tacrolimus is administered in conjunction with other medications to inhibit …

Leave a Reply

Your email address will not be published. Required fields are marked *